Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CG Oncology, Inc.CGON · Entity 3735 | Director | September 03, 2025 | September 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CG Oncology, Inc.
Report date September 03, 2025 · Filed September 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Chaming Jade Limited | 2,934,236 |
Reported balance
After 2025-09-03 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-09-03 · Sale · Disposed 69,695 · Balance 2,934,236 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Charming Jade Limited | 2,903,931 |
Last balance in matching sequence
After 2025-09-03 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 2 · 2025-09-03 · Sale · Disposed 30,105 · Balance 2,904,131 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Row 3 · 2025-09-03 · Sale · Disposed 100 · Balance 2,904,031 F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Row 4 · 2025-09-03 · Sale · Disposed 100 · Balance 2,903,931 F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Unique Diamond Investments Limited | 586,982 |
Reported balance
Holding disclosure · report date 2025-09-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 586,982 F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. F5: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc. |
| Common StockSEC Table I · non-derivative | Direct | 613,928 |
Reported balance
Holding disclosure · report date 2025-09-03 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 613,928 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.
F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2025 Filed Sep 4, 2025 21:00 UTC | CG Oncology, Inc. CGON · Entity 3735 | SaleCommon Stock | 100 | $28.99 | $2,899.00 |
DisclosureSEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 4 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Charming Jade Limited Disclosed balance after: 2,903,931 F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 21:00 UTC | CG Oncology, Inc. CGON · Entity 3735 | SaleCommon Stock | 100 | $28.96 | $2,896.00 |
DisclosureSEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 3 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Charming Jade Limited Disclosed balance after: 2,904,031 F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 21:00 UTC | CG Oncology, Inc. CGON · Entity 3735 | SaleCommon Stock | 30,105 | $28.24 | $850,165.20 |
DisclosureSEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 2 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Charming Jade Limited Disclosed balance after: 2,904,131 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 21:00 UTC | CG Oncology, Inc. CGON · Entity 3735 | SaleCommon Stock | 69,695 | $27.60 | $1,923,582.00 |
DisclosureSEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 1 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Chaming Jade Limited Disclosed balance after: 2,934,236 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:00 UTC | CG Oncology, Inc. CGON · Entity 3735 | GrantDirector Stock Option (right to buy) · Derivative | 24,165 | $0.00 Strike: $26.63 | $0.00 |
DisclosureSEC source: 0000950170-25-083239 · ownership.xml · derivative · entry 1 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,165 Underlying: Common Stock · 24,165 shares Expires 2035-06-04 F1 · derivative.exercise_date: 1/12th of the total number of shares of common stock subject to the option vest monthly following June 5, 2025, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 23:03 UTC | CG Oncology, Inc. CGON · Entity 3735 | SaleCommon Stock | 700,000 | $28.00 | $19,600,000.00 |
DisclosureSEC source: 0001415889-24-029664 · form4-12172024_111213.xml · nonDerivative · entry 1 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Charming Jade Limited Disclosed balance after: 3,003,931 F1 · kind: The shares were offered and sold by Charming Jade Limited in connection with the Issuer's public offering pursuant to the Registration Statement on Form S-1 (File No. 333-283725) that closed on December 16, 2024. F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| October 04, 2024 Filed Oct 7, 2024 21:03 UTC | CG Oncology, Inc. CGON · Entity 3735 | GrantStock Option (Right to Buy) · Derivative | 15,600 | $0.00 Strike: $36.63 | $0.00 |
DisclosureSEC source: 0000950170-24-113304 · ownership.xml · derivative · entry 1 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,600 Underlying: Common Stock · 15,600 shares Expires 2034-10-03 F1 · derivative.exercise_date: 1/12th of the total number of shares of common stock subject to the option vest monthly following October 4, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 23:18 UTC | CG Oncology, Inc. CGON · Entity 3735 | SaleCommon Stock | 226,245 | $35.36 | $8,000,023.20 |
DisclosureSEC source: 0000950170-24-102496 · ownership.xml · nonDerivative · entry 2 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Charming Jade Limited Disclosed balance after: 3,703,931 F2 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. F3 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 23:18 UTC | CG Oncology, Inc. CGON · Entity 3735 | SaleCommon Stock | 424,210 | $35.36 | $15,000,065.60 |
DisclosureSEC source: 0000950170-24-102496 · ownership.xml · nonDerivative · entry 1 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Unique Diamond Investments Limited Disclosed balance after: 586,982 F1 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. F2 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | ConversionSeries E Preferred Stock · Derivative | 37,474,236 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 8 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Charming Jade Limited Disclosed balance after: 0 Underlying: Common Stock · 3,930,176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. F4 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | ConversionSeries D Preferred Stock · Derivative | 3,378,758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 7 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Unique Diamond Investments Limited Disclosed balance after: 0 Underlying: Common Stock · 354,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | ConversionSeries C Preferred Stock · Derivative | 6,262,967 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 6 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Unique Diamond Investments Limited Disclosed balance after: 0 Underlying: Common Stock · 656,839 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | ConversionSeries B Preferred Stock · Derivative | 3,344,608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 5 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | PurchaseCommon Stock | 263,157 | $19.00 | $4,999,983.00 |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 4 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 613,928 Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | ConversionCommon Stock | 3,930,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 3 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Charming Jade Limited Disclosed balance after: 3,930,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. F4 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | ConversionCommon Stock | 1,011,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 2 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Unique Diamond Investments Limited Disclosed balance after: 1,011,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | CG Oncology, Inc. CGON · Entity 3735 | ConversionCommon Stock | 350,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 1 Song Hong Fang · CIK 0002008157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.